Rite Aid (RAD) Tops Q3 EPS by 5c; Raises FY12 Outlook
Tweet
Share
E-mail
Get Alerts RAD Hot Sheet
Price: $0.65 --0%
Financial Fact:
Total costs and expenses: 8B
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Total costs and expenses: 8B
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Rite Aid (NYSE: RAD) reported Q3 EPS of ($0.06), $0.05 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $6.31 billion versus the consensus estimate of $6.29 billion.
Rite Aid sees FY2012 EPS of $-0.50-$-0.37, versus prior guidance of $-0.56-$-0.40. Rite Aid sees FY2012 revenue of $25.85-$26.0 billion, versus prior guidance of $25.8-$26.1 billion and the consensus of $25.86 billion.
Rite Aid sees FY2012 EPS of $-0.50-$-0.37, versus prior guidance of $-0.56-$-0.40. Rite Aid sees FY2012 revenue of $25.85-$26.0 billion, versus prior guidance of $25.8-$26.1 billion and the consensus of $25.86 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
